Literature DB >> 11065340

Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features.

C Mrowka1, A Schedl.   

Abstract

Normal development of the kidney is a highly complex process that requires precise orchestration of proliferation, differentiation, and apoptosis. In the past few years, a number of genes that regulate these processes, and hence play pivotal roles in kidney development, have been identified. The Wilms' tumor suppressor gene WT1 has been shown to be one of these essential regulators of kidney development, and mutations in this gene result in the formation of tumors and developmental abnormalities such as the Denys-Drash and Frasier syndromes. A fascinating aspect of the WT1 gene is the multitude of isoforms produced from its genomic locus. In this review, our current understanding of the structural features of WT1, how they modulate the transcriptional and post-transcriptional activities of the protein, and how mutations affecting individual isoforms can lead to diseased kidneys is summarized. In addition, results from transgenic experiments, which have yielded important findings regarding the function of WT1 in vivo, are discussed. Finally, data on the unusual feature of RNA editing of WT1 transcripts are presented, and the relevance of RNA editing for the normal functioning of the WT1 protein in the kidney is discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11065340

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  14 in total

Review 1.  When you can't trust the DNA: RNA editing changes transcript sequences.

Authors:  Volker Knoop
Journal:  Cell Mol Life Sci       Date:  2010-10-12       Impact factor: 9.261

2.  Genotype/phenotype correlation in nephrotic syndrome caused by WT1 mutations.

Authors:  Gil Chernin; Virginia Vega-Warner; Dominik S Schoeb; Saskia F Heeringa; Bugsu Ovunc; Pawaree Saisawat; Roxana Cleper; Fatih Ozaltin; Friedhelm Hildebrandt
Journal:  Clin J Am Soc Nephrol       Date:  2010-07-01       Impact factor: 8.237

Review 3.  Growing evidence suggests WT1 effects in the kidney development are modulated by Hsp70/NO interaction.

Authors:  Luciana Mazzei; Walter Manucha
Journal:  J Nephrol       Date:  2016-04-08       Impact factor: 3.902

Review 4.  PAX2 in human kidney malformations and disease.

Authors:  Lyndsay A Harshman; Patrick D Brophy
Journal:  Pediatr Nephrol       Date:  2011-12-03       Impact factor: 3.714

Review 5.  WT1 and glomerular diseases.

Authors:  Patrick Niaudet; Marie-Claire Gubler
Journal:  Pediatr Nephrol       Date:  2006-08-23       Impact factor: 3.714

6.  Regulation of vascular endothelial growth factor, VEGF, gene promoter by the tumor suppressor, WT1.

Authors:  Julie Hanson; Jacquelyn Gorman; Jennifer Reese; Gail Fraizer
Journal:  Front Biosci       Date:  2007-01-01

Review 7.  Congenital nephrotic syndrome.

Authors:  Asmaa S AbuMaziad; Rami Abusaleh; Shanti Bhati
Journal:  J Perinatol       Date:  2022-01-04       Impact factor: 2.521

Review 8.  Congenital nephrotic syndrome.

Authors:  Hannu Jalanko
Journal:  Pediatr Nephrol       Date:  2007-10-30       Impact factor: 3.714

9.  A mutation in the start codon of γ-crystallin D leads to nuclear cataracts in the Dahl SS/Jr-Ctr strain.

Authors:  Ashley C Johnson; Jonathan W Lee; Ashlyn C Harmon; Zaliya Morris; Xuexiang Wang; Jonathan Fratkin; John P Rapp; Elise Gomez-Sanchez; Michael R Garrett
Journal:  Mamm Genome       Date:  2013-02-13       Impact factor: 2.957

10.  Congenital nephrotic syndrome with prolonged renal survival without renal replacement therapy.

Authors:  William Wong; Maxwell Clarke Morris; Tonya Kara
Journal:  Pediatr Nephrol       Date:  2013-08-15       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.